M. Billeter

Clinical Infectious Diseases · 2007–2019

A researcher in the Science corpus: 3 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.

Papers from M. Billeter's perspective

Ordered by how strongly the researchers M. Billeter trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of… (American Journal of Health-System Pharmacy)
  2. High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity. (Archives of Internal Medicine)
  3. Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia (Journal of Clinical Microbiology)
  4. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. (Clinical Infectious Diseases)
  5. The impact of antimicrobial resistance on health and economic outcomes. (Clinical Infectious Diseases)
  6. Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. (American Journal of Medicine)
  7. The pharmacokinetic and pharmacodynamic properties of vancomycin. (Clinical Infectious Diseases)
  8. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. (Clinical Infectious Diseases)
  9. Autoinduction and signal transduction in the regulation of staphylococcal virulence (Molecular Microbiology)
  10. Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections. (Clinical Infectious Diseases)

Their papers